TXA dosing for heart surgery patients on bypass
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for planned (elective) cardiovascular surgery that uses a heart-lung bypass machine
- You can sign written consent to join the study
- You are not pregnant
- You are not refusing blood from other people (donated/banked blood transfusions)
- You are not allergic to tranexamic acid (TXA)
- You do not have certain clotting risks or recent major stroke/heart attack
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.
This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.
This study tests whether taking tranexamic acid (a medication that helps blood clot) for a few days after knee replacement surgery can reduce bleeding and the need for blood transfusions. It may help patients recover with fewer complications.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
Hear when a new Heart Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.